These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6388097)

  • 1. Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
    Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
    Trans Assoc Am Physicians; 1983; 96():1-9. PubMed ID: 6388097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
    Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4124-8. PubMed ID: 6575399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of LDL receptors in vivo.
    Bilheimer DW
    Agents Actions Suppl; 1984; 16():191-203. PubMed ID: 6592957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation.
    East C; Grundy SM; Bilheimer DW
    JAMA; 1986 Nov; 256(20):2843-8. PubMed ID: 3534334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholesterolemia.
    Grundy SM; Vega GL; Bilheimer DW
    Ann Intern Med; 1985 Sep; 103(3):339-43. PubMed ID: 3849281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
    Illingworth DR
    Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercholesterolemia persisting after distal ileal bypass: response to mevinolin.
    Illingworth DR; Connor WE
    Ann Intern Med; 1984 Jun; 100(6):850-1. PubMed ID: 6562870
    [No Abstract]   [Full Text] [Related]  

  • 8. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis.
    Goldstein JL; Brown MS
    Circulation; 1987 Sep; 76(3):504-7. PubMed ID: 3621516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering plasma cholesterol by raising LDL receptors.
    Brown MS; Goldstein JL
    N Engl J Med; 1981 Aug; 305(9):515-7. PubMed ID: 6265781
    [No Abstract]   [Full Text] [Related]  

  • 11. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholeserolemia heterozygotes. 1983.
    Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
    Atheroscler Suppl; 2004 Oct; 5(3):61-5. PubMed ID: 15531277
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.
    Grundy SM; Bilheimer DW
    Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2538-42. PubMed ID: 6371816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein fractions and receptors: a role for probucol?
    Bilheimer DW
    Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of LDL receptor function by lymphocytes of patients with heterozygous familial hypercholesterolemia after treatment with plasma cholesterol lowering agents.
    Cuthbert JA; East CA; Lipsky PE
    Am J Med Sci; 1989 Sep; 298(3):152-60. PubMed ID: 2552800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR; Bacon S
    Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia.
    Hoeg JM; Maher MB; Zech LA; Bailey KR; Gregg RE; Lackner KJ; Fojo SS; Anchors MA; Bojanovski M; Sprecher DL
    Am J Cardiol; 1986 Apr; 57(11):933-9. PubMed ID: 3515897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
    Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.
    Naoumova RP; Marais AD; Mountney J; Firth JC; Rendell NB; Taylor GW; Thompson GR
    Atherosclerosis; 1996 Jan; 119(2):203-13. PubMed ID: 8808497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR; Sexton GJ
    J Clin Invest; 1984 Dec; 74(6):1972-8. PubMed ID: 6569064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pravastatin in relation to low density lipoprotein receptor activity.
    Hayashi H; Naito C; Ito H; Kawamura M; Miyazaki S
    Curr Med Res Opin; 1990; 12(2):100-7. PubMed ID: 2118022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.